World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02412774
Date of registration: 06/04/2015
Prospective Registration: No
Primary sponsor: Novindiet Clinic
Public title: Effects of Replacing Diet Beverages With Water on Weight Loss and Plasma Glucose Control in Type 2 Diabetes
Scientific title: Effects of Replacing Diet Beverages With Water on Type 2 Diabetic Obese Females Attending a Weight Loss Program - a Randomized, 24 Week Clinical Trial
Date of first enrolment: April 2015
Target sample size: 81
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02412774
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Iran, Islamic Republic of
Contacts
Name:     Alireza Delavari, MD
Address: 
Telephone:
Email:
Affiliation:  Digestive Disease Research Institute, Tehran University of Medical Sciences
Name:     Reza Malekzadeh, Prof.
Address: 
Telephone:
Email:
Affiliation:  Digestive Disease Research Institute, Tehran University of Medical Sciences
Name:     Hamid R Farshchi, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  NovinDiet Clinic, School of Life Sciences, The University of Nottingham
Name:     Ian A Macdonald, Prof.
Address: 
Telephone:
Email:
Affiliation:  School of Life Sciences, The University of Nottingham
Name:     Ameneh Madjd, Dr
Address: 
Telephone:
Email:
Affiliation:  NovinDiet Clinic, School of Life Sciences, The University of Nottingham
Name:     Moira A Taylor, PhD
Address: 
Telephone:
Email:
Affiliation:  School of Life Sciences, The University of Nottingham
Key inclusion & exclusion criteria

Inclusion Criteria:

- Diabetic female patient with 6.5
- Monotherapy with Metformin.

- 18-45 years of age.

- Body mass index (BMI) between 27-35 kg/ m².

- Consume DBs regularly during their habitual diet.

- Must be able to have moderate exercise.

- Must be interested to have weight loss.

Exclusion Criteria:

- Participating in a research project involving weight loss or physical activity in the
previous six months.

- Pregnancy or lactation during the previous 6 months, or planned pregnancy in the next
six months.

- Taking medication that could affect metabolism or change body weight.

- Report heart problems, chest pain, and cancer within the last five years.

- Unwilling to change intake of beverages during the study period.



Age minimum: 18 Years
Age maximum: 45 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Type 2 Diabetes
Obese
Overweight
Intervention(s)
Behavioral: DBs at the end of the main meal + Diet
Behavioral: Water at the end of the main meal+ Diet
Primary Outcome(s)
Weight loss [Time Frame: 24 weeks]
Secondary Outcome(s)
Fasting plasma glucose [Time Frame: 24 weeks]
Waist circumference [Time Frame: 24 weeks]
Insulin resistance (HOMA) [Time Frame: 24 weeks]
Lipid profiles [Time Frame: 24 weeks]
BMI [Time Frame: 24 Weeks]
HA1C [Time Frame: 24 Weeks]
Secondary ID(s)
ND-107
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Tehran University of Medical Sciences
University of Nottingham
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history